Do analysts recommend CTSO or TNON?

Cytosorbents currently has a consensus target price of $5.38, suggesting a potential upside of 1,102.46%. Given Cytosorbents' higher possible upside, equities research analysts plainly believe Cytosorbents is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytosorbents 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is CTSO or TNON more profitable?

Cytosorbents has a net margin of -31.85% compared to Tenon Medical's net margin of -270.09%. Cytosorbents' return on equity of -235.57% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Cytosorbents -31.85% -235.57% -37.88% Tenon Medical -270.09% -907.60% -110.17%

Do analysts recommend PETV or TNON?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is PETV or TNON more profitable?

Tenon Medical has a net margin of -270.09% compared to PetVivo's net margin of -902.82%. Tenon Medical's return on equity of -907.60% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Tenon Medical -270.09% -907.60% -110.17%

Do analysts prefer CODX or TNON?

Co-Diagnostics presently has a consensus target price of $67.50, suggesting a potential upside of 939.26%. Given Co-Diagnostics' higher probable upside, analysts clearly believe Co-Diagnostics is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Co-Diagnostics 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is CODX or TNON more profitable?

Tenon Medical has a net margin of -270.09% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Co-Diagnostics -6,760.63% -164.92% -141.15% Tenon Medical -270.09% -907.60% -110.17%

Do analysts rate POAI or TNON?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer TNON or FEMY?

Femasys has a consensus target price of $5.33, suggesting a potential upside of 1,365.20%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better earnings & valuation, TNON or FEMY?

Tenon Medical has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tenon Medical $3.94M 1.82 -$12.56M -$1.29 N/A Femasys $2.29M 9.60 -$18.63M -$0.27 N/A

Is TNON or FEMY more profitable?

Tenon Medical has a net margin of -270.09% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Tenon Medical -270.09% -907.60% -110.17% Femasys -521.97% -258.08% -73.72%

Tenon Medical (TNON) Competitors

$0.61 -0.06 (-9.59%)

As of 02:28 PM Eastern

Compare

TNON vs. CTSO, PETV, CODX, POAI, and FEMY

Should you buy Tenon Medical stock or one of its competitors? MarketBeat compares Tenon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tenon Medical include Cytosorbents (CTSO), PetVivo (PETV), Co-Diagnostics (CODX), Predictive Oncology (POAI), and Femasys (FEMY). These companies are all part of the "medical equipment" industry.

How does Tenon Medical compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

Cytosorbents has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Cytosorbents currently has a consensus target price of $5.38, suggesting a potential upside of 1,102.46%. Given Cytosorbents' higher possible upside, equities research analysts plainly believe Cytosorbents is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cytosorbents has higher revenue and earnings than Tenon Medical. Cytosorbents is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.06M	0.76	-$8.20M	-$0.19	N/A
Tenon Medical	$3.94M	1.82	-$12.56M	-$1.29	N/A

32.9% of Cytosorbents shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 6.6% of Cytosorbents shares are owned by company insiders. Comparatively, 0.3% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Cytosorbents had 1 more articles in the media than Tenon Medical. MarketBeat recorded 2 mentions for Cytosorbents and 1 mentions for Tenon Medical. Tenon Medical's average media sentiment score of 1.89 beat Cytosorbents' score of 0.44 indicating that Tenon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Cytosorbents	Neutral
Tenon Medical	Very Positive

Cytosorbents has a net margin of -31.85% compared to Tenon Medical's net margin of -270.09%. Cytosorbents' return on equity of -235.57% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-31.85%	-235.57%	-37.88%
Tenon Medical	-270.09%	-907.60%	-110.17%

Summary

Cytosorbents beats Tenon Medical on 11 of the 14 factors compared between the two stocks.

How does Tenon Medical compare to PetVivo?

PetVivo (NASDAQ:PETV) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

In the previous week, Tenon Medical had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for Tenon Medical and 0 mentions for PetVivo. Tenon Medical's average media sentiment score of 1.89 beat PetVivo's score of 0.00 indicating that Tenon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
PetVivo	Neutral
Tenon Medical	Very Positive

Tenon Medical has a net margin of -270.09% compared to PetVivo's net margin of -902.82%. Tenon Medical's return on equity of -907.60% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Tenon Medical	-270.09%	-907.60%	-110.17%

PetVivo has higher earnings, but lower revenue than Tenon Medical. PetVivo is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.37	-$10.95M	-$0.38	N/A
Tenon Medical	$3.94M	1.82	-$12.56M	-$1.29	N/A

24.5% of PetVivo shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 0.3% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

PetVivo has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

Summary

Tenon Medical beats PetVivo on 9 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to Co-Diagnostics?

Co-Diagnostics (NASDAQ:CODX) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

Co-Diagnostics presently has a consensus target price of $67.50, suggesting a potential upside of 939.26%. Given Co-Diagnostics' higher probable upside, analysts clearly believe Co-Diagnostics is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 5.4% of Co-Diagnostics shares are owned by insiders. Comparatively, 0.3% of Tenon Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Co-Diagnostics had 11 more articles in the media than Tenon Medical. MarketBeat recorded 12 mentions for Co-Diagnostics and 1 mentions for Tenon Medical. Tenon Medical's average media sentiment score of 1.89 beat Co-Diagnostics' score of 0.31 indicating that Tenon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Co-Diagnostics	Neutral
Tenon Medical	Very Positive

Co-Diagnostics has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

Tenon Medical has higher revenue and earnings than Co-Diagnostics. Tenon Medical is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Co-Diagnostics	$718.17K	32.58	-$46.90M	-$15.77	N/A
Tenon Medical	$3.94M	1.82	-$12.56M	-$1.29	N/A

Tenon Medical has a net margin of -270.09% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%
Tenon Medical	-270.09%	-907.60%	-110.17%

Summary

Tenon Medical beats Co-Diagnostics on 7 of the 13 factors compared between the two stocks.

How does Tenon Medical compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

In the previous week, Tenon Medical had 1 more articles in the media than Predictive Oncology. MarketBeat recorded 1 mentions for Tenon Medical and 0 mentions for Predictive Oncology. Tenon Medical's average media sentiment score of 1.89 beat Predictive Oncology's score of 0.00 indicating that Tenon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Predictive Oncology	Neutral
Tenon Medical	Very Positive

Predictive Oncology has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Tenon Medical has a net margin of -270.09% compared to Predictive Oncology's net margin of -5,065.23%. Predictive Oncology's return on equity of -732.73% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
Tenon Medical	-270.09%	-907.60%	-110.17%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 1.2% of Predictive Oncology shares are held by company insiders. Comparatively, 0.3% of Tenon Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Tenon Medical has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66M	14.80	-$12.66M	-$13.50	N/A
Tenon Medical	$3.94M	1.82	-$12.56M	-$1.29	N/A

Summary

Tenon Medical beats Predictive Oncology on 11 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to Femasys?

Tenon Medical (NASDAQ:TNON) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Tenon Medical has a net margin of -270.09% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-907.60%	-110.17%
Femasys	-521.97%	-258.08%	-73.72%

Tenon Medical has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94M	1.82	-$12.56M	-$1.29	N/A
Femasys	$2.29M	9.60	-$18.63M	-$0.27	N/A

Tenon Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Femasys has a beta of -2.23, suggesting that its share price is 323% less volatile than the broader market.

Femasys has a consensus target price of $5.33, suggesting a potential upside of 1,365.20%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Tenon Medical and Tenon Medical both had 1 articles in the media. Tenon Medical's average media sentiment score of 1.89 beat Femasys' score of 1.87 indicating that Tenon Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Tenon Medical	Very Positive
Femasys	Very Positive

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by company insiders. Comparatively, 7.6% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Femasys beats Tenon Medical on 9 of the 15 factors compared between the two stocks.

Get Tenon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TNON vs. The Competition

Export

Metric	Tenon Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.99M	$7.17B	$6.39B	$12.59B
Dividend Yield	N/A	1.34%	2.69%	5.30%
P/E Ratio	-0.52	44.83	21.16	26.60
Price / Sales	1.82	72.95	512.63	95.38
Price / Cash	N/A	25.15	27.44	37.60
Price / Book	3.44	7.29	9.81	6.77
Net Income	-$12.56M	$157.37M	$3.56B	$337.23M
7 Day Performance	-10.42%	3.95%	0.31%	2.65%
1 Month Performance	-20.75%	6.94%	4.68%	6.63%
1 Year Performance	-42.59%	4.83%	31.03%	37.91%

Tenon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TNON Tenon Medical	1.403 of 5 stars	$0.62 -7.7%	N/A	-37.2%	$7.99M	$3.94M	N/A	8	Positive News Gap Up High Trading Volume
CTSO Cytosorbents	1.8411 of 5 stars	$0.47 +2.0%	$5.38 +1,038.8%	-46.2%	$29.64M	$37.06M	N/A	220	Gap Up
PETV PetVivo	N/A	$0.79 -0.3%	N/A	-8.6%	$28.43M	$1.05M	N/A	20	Gap Down
CODX Co-Diagnostics	2.1799 of 5 stars	$6.95 -23.7%	$67.50 +871.2%	-21.1%	$24.97M	$718.17K	N/A	100	Short Interest Increase Gap Up Trading Halted
POAI Predictive Oncology	N/A	$6.92 +29.6%	N/A	-48.4%	$23.49M	$1.66M	N/A	30	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TNON) was last updated on 6/2/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tenon Medical (TNON) Competitors

TNON vs. CTSO, PETV, CODX, POAI, and FEMY

How does Tenon Medical compare to Cytosorbents?

Summary

How does Tenon Medical compare to PetVivo?

Summary

How does Tenon Medical compare to Co-Diagnostics?

Summary

How does Tenon Medical compare to Predictive Oncology?

Summary

How does Tenon Medical compare to Femasys?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON vs. The Competition

Tenon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tenon Medical (TNON) Competitors

TNON vs. CTSO, PETV, CODX, POAI, and FEMY

How does Tenon Medical compare to Cytosorbents?

Which has more risk & volatility, CTSO or TNON?

Do analysts recommend CTSO or TNON?

Which has stronger earnings & valuation, CTSO or TNON?

Do insiders & institutionals hold more shares of CTSO or TNON?

Does the media prefer CTSO or TNON?

Is CTSO or TNON more profitable?

Summary

How does Tenon Medical compare to PetVivo?

Does the media prefer PETV or TNON?

Is PETV or TNON more profitable?

Which has higher valuation and earnings, PETV or TNON?

Do institutionals & insiders hold more shares of PETV or TNON?

Do analysts recommend PETV or TNON?

Which has more volatility and risk, PETV or TNON?

Summary

How does Tenon Medical compare to Co-Diagnostics?

Do analysts prefer CODX or TNON?

Do insiders & institutionals have more ownership in CODX or TNON?

Does the media prefer CODX or TNON?

Which has more volatility and risk, CODX or TNON?

Which has preferable valuation & earnings, CODX or TNON?

Is CODX or TNON more profitable?

Summary

How does Tenon Medical compare to Predictive Oncology?

Does the media favor POAI or TNON?

Which has more volatility and risk, POAI or TNON?

Is POAI or TNON more profitable?

Do analysts rate POAI or TNON?

Do insiders and institutionals believe in POAI or TNON?

Which has higher valuation and earnings, POAI or TNON?

Summary

How does Tenon Medical compare to Femasys?

Is TNON or FEMY more profitable?

Which has better earnings & valuation, TNON or FEMY?

Which has more risk & volatility, TNON or FEMY?

Do analysts prefer TNON or FEMY?

Does the media refer more to TNON or FEMY?

Do institutionals and insiders have more ownership in TNON or FEMY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNON vs. The Competition

Tenon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools